A Comparison Of Markov Cohort And Discrete Event Simulation Models In Cost-Effectiveness Analysis Of Sorafenib And Everolimus In 3rd Line Metastatic Renal-Cell Carcinoma In The Czech Republic
Abstract
Authors
T Mlcoch K Lamblova E Ornstova T Dolezal